ASP Isotopes subsidiary signs research deal with Texas state agency

ASP Isotopes Unit Signs Nuclear Fuel Research Deal

ASP Isotopes - Agreement Advances Qle's Scalable Domestic Uranium Conversion Technology for U.S. Nuclear Fuel Supply

ASP Isotopes - Qle Signs Research Agreement with Texas A&m to Advance Uf6 Production

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&m Engineering Experiment Station to Advance Uranium Conversion Technology

ENDRA Life Sciences Agrees to Merge with ASP Isotopes Unit Noble Africa in Deal Set to Create Nasdaq-listed NOBA

ASP Isotopes Files for Resale of 23.2 Million Shares

ASP Isotopes files to sell 23.16M shares of common stock for holders

ASP Isotopes Inc - Files to Offer & Sale by Selling Stockholders of 23.2 Mln Shares of Common Stock - Filing

ASP Isotopes Reaches Deal in Principle to Settle Securities Class Action in New York Federal Court

Top Midday Decliners

ASP Isotopes Swaps $109.2 Million QLE Notes for 23,200,000 Shares in Private Exchange Deal

ASP Isotopes to exchange certain QLE convertible notes for ASPI common stock

ASP Isotopes Announces Agreements to Exchange Certain Qle Convertible Notes for Aspi Common Stock

ASP Isotopes - Qle Noteholders to Exchange $109.2 Mln for 23.2 Mln Aspi Shares, 17.8% of Outstanding Stock

ASP Isotopes EVP, General Counsel Donald Ainscow Disposes of 100,000 Common Shares Worth $614,000

ASP Isotopes Director Michael Gorley Sells 30,000 Shares Worth $188,100

Jse: Iso - Form 144 – Report of Proposed Sale of Securities

Jse: Iso - Form 144 – Report of Proposed Sale of Securities